Alexion Pharmaceuticals To Pay SEC $21M Over FCPA Claims
Alexion Pharmaceuticals will shell out almost $21.5 million to settle U.S. Securities and Exchange Commission claims that two Alexion subsidiaries bribed Russian and Turkish officials to secure preferential treatment for its...To view the full article, register now.
Already a subscriber? Click here to view full article